www.bafirm.com/2018/08/astrazeneca-settles-texas-medicaid-fraud-suits-110m

Aug 20, 2018 ... AstraZeneca Settles Texas Medicaid Fraud Suits For $110M ... AstraZeneca LP et al., number D-1-GN-13-003530, and State of Texas ... Layne D. Foote, Mark T. Lorden, Rosemarie De Souza and Kenneth McDonough, M.D. v.

www.bloomberg.com/news/articles/2018-08-07/astrazeneca-to-pay-110-million-to-settle-texas-drug-suits-jkk6v647

Aug 7, 2018 ... AstraZeneca Plc agreed to pay $110 million to settle a Texas claim alleging that the ... Texas claimed AstraZeneca promoted Seroquel to Medicaid providers who ... The case is the State of Texas v. AstraZeneca LP, No.

caselaw.findlaw.com/us-3rd-circuit/1681038.html

ASTRAZENECA PHARMACEUTICALS L.P.; Astrazeneca LP; Bristol–Myers ... 31 U.S.C. § 3729 et seq., and corresponding state laws, appeals the District ...

law.justia.com/cases/federal/appellate-courts/ca1/15-2232/15-2232-2017-05-02.html

Plaintiff appealed the district court's grant of summary judgment in favor of her former employer, AstraZeneca Pharmaceutical LP, on Plaintiff's claims that ...

www.astrazeneca.com

AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

www.ncbi.nlm.nih.gov/pmc/articles/PMC5880376

Apr 2, 2018 ... However, the discovery by Liu, et al. ..... All work was performed at IHMA and sponsored by AstraZeneca Pharmaceuticals, LP, which also included compensation fees ... Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, et al. mcr-1.2, a New mcr variant carried on a transferable  ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC6012561

May 31, 2018 ... Filippo de Marinis,1 Fortunato Ciardiello,2 Paul Baas,3 Lucio Crinò,4 Giuseppe Giaccone,5 .... OS was significantly improved in favour of nivolumab (median 9.2 vs 6.0 months, ..... LP-A receiving honoraria AstraZeneca, Pfizer, Bristol-Myers Squibb, MerckSharp ... Passaro A, Lazzari C, Karachaliou N, et al.

citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.612.9214&rep=rep1&type=pdf

Paolo Maione,a Cesare Gridelli,a Teresa Troiani,b Fortunato Ciardiellob. aDivision of Medical .... EGFR-TK Thatcher et al. [9]. Gefitinib vs. best supportive care. Second- or third- line treatment .... tipifarnib (Zarnestra™; Ortho Biotech Products, L.P.,. Bridgewater, NJ) ..... sultant for AstraZeneca and sanofi-aventis. References.

journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0195281&type=printable

Apr 2, 2018 ... sponsored by AstraZeneca Pharmaceuticals, LP, which also included compensation ..... 2016. 15. Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S, et al. mcr-1.2, a New mcr variant carried on a ...